menu
    • menu

    Company profile for Boundless Bio

    NEW Drugs in Dev: 3
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Developing an entirely new class of therapeutics requires boldness, commitment, creativity, and an entrepreneurial spirit. We are building a team of pioneers committed to driving a scientific revolution in how the most difficult-to-treat cancers are understood and treated. Above all else, our commitment is to the patients we strive to help. We aim to create the first therapeutics capable of dismantling one of cancer’s tricki...
    Developing an entirely new class of therapeutics requires boldness, commitment, creativity, and an entrepreneurial spirit. We are building a team of pioneers committed to driving a scientific revolution in how the most difficult-to-treat cancers are understood and treated. Above all else, our commitment is to the patients we strive to help. We aim to create the first therapeutics capable of dismantling one of cancer’s trickiest evasive mechanisms – ecDNA.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Boundless BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11099 North Torrey Pines Rd, Suite 280, La Jolla, CA, 92037
    Telephone
    Telephone
    858-766-9912
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://boundlessbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/boundlessbio/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/BoundlessBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Boundless Bio Reports Q1 2026 Results and Business Highlights
    Boundless Bio Reports Q1 2026 Results and Business Highlights

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3290993/0/en/boundless-bio-reports-first-quarter-2026-financial-results-and-business-highlights.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Boundless Bio Presents Kinesin Degrader Data at AACR 2026
    Boundless Bio Presents Kinesin Degrader Data at AACR 2026

    19 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7187530

    FIRSTWORD PHARMA
    19 Apr 2026
    Share Share
    Boundless Bio to Present Preclinical Degrader Program at 2026
    Boundless Bio to Present Preclinical Degrader Program at 2026

    17 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/17/3276505/0/en/Boundless-Bio-Presents-Preclinical-Breast-Cancer-Data-from-its-Oral-Kinesin-Degrader-Program-at-2026-AACR-Annual-Meeting.html

    GLOBENEWSWIRE
    17 Apr 2026
    Share Share
    Boundless Bio To Present Oral Kinesin Degrader Program At AACR
    Boundless Bio To Present Oral Kinesin Degrader Program At AACR

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257713/0/en/Boundless-Bio-Announces-Upcoming-Presentation-of-Oral-Kinesin-Degrader-Program-at-the-American-Association-for-Cancer-Research-Annual-Meeting-2026.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Boundless Bio Reports Q4 & FY 2025 Results, Business Update
    Boundless Bio Reports Q4 & FY 2025 Results, Business Update

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251668/0/en/Boundless-Bio-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Business-Highlights.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Boundless Bio To Join Leerink Global Healthcare Conference
    Boundless Bio To Join Leerink Global Healthcare Conference

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249203/0/en/Boundless-Bio-to-Participate-in-the-Leerink-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search